Naratriptan
Selective Serotonin (5ht1) Agonists
- Drug class
- Selective Serotonin (5ht1) Agonists
- Availability
- See label
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 17
Overview
Naratriptan is an active pharmaceutical ingredient in the Selective Serotonin (5ht1) Agonists group (N02CC). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 12 | May 15, 2026 |
| CA Canada | Health Canada | 5 | March 22, 2025 |
GBUnited Kingdom· MHRA
12 products
Uses
Naratriptan tablets are indicated for the Acute treatment of migraine attacks with or without aura. Naratriptan should not be used prophylactically.
How to take
CACanada· Health Canada
5 products
Uses
AND CLINICAL USE ..................................................................................... 3 CONTRAINDICATIONS .......................................................................................................... 4 WARNINGS AND PRECAUTIONS .........................................................................................
5 ADVERSE REACTIONS ......................................................................................................... 10 DRUG INTERACTIONS .........................................................................................................
14 DOSAGE AND ADMINISTRATION ..................................................................................... 15 OVERDOSAGE .......................................................................................................................
16 ACTION AND CLINICAL PHARMACOLOGY ................................................................... 17 STORAGE AND STABILITY ................................................................................................. 19 DOSAGE FORMS, COMPOSITION AND PACKAGING ....................................................
Drug interactions
Known interactions involving Naratriptan. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL204160376 · revised February 14, 2025
- [2]Health Canada (DPD) · 02314290 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.